Phillip LaRussa

1.2k total citations
16 papers, 862 citations indexed

About

Phillip LaRussa is a scholar working on Epidemiology, Virology and Animal Science and Zoology. According to data from OpenAlex, Phillip LaRussa has authored 16 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 6 papers in Virology and 4 papers in Animal Science and Zoology. Recurrent topics in Phillip LaRussa's work include Herpesvirus Infections and Treatments (10 papers), Poxvirus research and outbreaks (4 papers) and Animal Virus Infections Studies (4 papers). Phillip LaRussa is often cited by papers focused on Herpesvirus Infections and Treatments (10 papers), Poxvirus research and outbreaks (4 papers) and Animal Virus Infections Studies (4 papers). Phillip LaRussa collaborates with scholars based in United States, Cameroon and Puerto Rico. Phillip LaRussa's co-authors include Anne A. Gershon, Kimberly Freudigman, Sharon P. Steinberg, Eugene D. Shapiro, Marietta Vázquez, Sharon Steinberg, A. A. Gershon, Octavian Lungu, Paula W. Annunziato and Susan M. Staugaitis and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Clinical Infectious Diseases.

In The Last Decade

Phillip LaRussa

16 papers receiving 836 citations

Peers

Countries citing papers authored by Phillip LaRussa

Since Specialization

Citations

This map shows the geographic impact of Phillip LaRussa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip LaRussa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip LaRussa more than expected).

Fields of papers citing papers by Phillip LaRussa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip LaRussa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip LaRussa. The network helps show where Phillip LaRussa may publish in the future.

Co-authorship network of co-authors of Phillip LaRussa

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip LaRussa. A scholar is included among the top collaborators of Phillip LaRussa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip LaRussa. Phillip LaRussa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Vaccines and global health: COVID-19 vaccine development, strategy, and implementation symposium – Summary of the meeting at Vagelos College of Physicians and Surgeons (February 22–26, 2021, New York) 2023 ·Vaccine ·Wilmot James, Lawrence R. Stanberry, Phillip LaRussa, (unknown)	1
2	Comparison of the capacity between public and private health facilities to manage under-five children with febrile illnesses in Uganda 2017 ·Malaria Journal ·Esther Buregyeya, Elizeus Rutebemberwa, Phillip LaRussa, Sham Lal, Siân E. Clarke, Kristian Schultz Hansen, Pascal Magnussen, Anthony K. Mbonye	20
3	Herpes Zoster Caused by Vaccine-Strain Varicella Zoster Virus in an Immunocompetent Recipient of Zoster Vaccine 2014 ·Clinical Infectious Diseases ·Hung Fu Tseng, D. Scott Schmid, Rafael Harpaz, Phillip LaRussa, Nancy J. Jensen, Pierre Rivailler, Kristen J. Radford, Jason P. Folster, Steven J. Jacobsen	39
4	Impaired Immunity to Recall Antigens and Neoantigens in Severely Immunocompromised Children and Adolescents during the First Year of Effective Highly Active Antiretroviral Therapy 2008 ·The Journal of Infectious Diseases ·Mona Rigaud, William Borkowsky, Petronella Muresan, Adriana Weinberg, Phillip LaRussa, Terry Fenton, Jennifer S. Read, Patrick Jean‐Philippe, (unknown), Bonnie Zimmer, (unknown), Joyce Kraimer	26
5	Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women 2008 ·AIDS Care ·Claude A. Mellins, (unknown), Kathleen Malee, (unknown), (unknown), Lynnette Harris, (unknown), C. Zorrilla, Sheldon H. Landesman, Leslie Serchuck, Phillip LaRussa	105
6	Effects of Polymorphisms of Chemokine Receptors on Neurodevelopment and the Onset of Encephalopathy in Children with Perinatal HIV-1 Infection 2006 ·Applied Neuropsychology ·Antolin M. Llorente, Pim Brouwers, Bruce Thompson, Irene H. Cheng, Carol Macmillan, Phillip LaRussa, Lynne Mofenson, Ileana Blasini, Cynthia Chase	4
7	Ocular complications of smallpox vaccination 2003 ·American Journal of Ophthalmology ·Jay S. Pepose, Todd P. Margolis, Phillip LaRussa, Deborah Pavan‐Langston	37
8	Disseminated Varicella Infection Due to the Vaccine Strain of Varicella‐Zoster Virus, in a Patient with a Novel Deficiency in Natural Killer T Cells 2003 ·The Journal of Infectious Diseases ·Ofer Levy, Jordan S. Orange, Patricia L. Hibberd, Sharon Steinberg, Phillip LaRussa, Adriana Weinberg, S. Brian Wilson, Angela Shaulov, Gary Fleisher, Raif S. Geha, Francisco A. Bonilla, Mark A. Exley	126
9	The Effectiveness of the Varicella Vaccine in Clinical Practice 2001 ·New England Journal of Medicine ·Marietta Vázquez, Phillip LaRussa, Anne A. Gershon, Sharon P. Steinberg, Kimberly Freudigman, Eugene D. Shapiro	265
10	VARICELLA VACCINE 1998 ·The Pediatric Infectious Disease Journal ·Anne A. Gershon, Phillip LaRussa	6
11	The Protective Effect of Immunologic Boosting against Zoster: An Analysis in Leukemic Children Who Were Vaccinated against Chickenpox 1996 ·The Journal of Infectious Diseases ·Anne A. Gershon, Phillip LaRussa, Sharon Steinberg, Nancy Mervish, S. H. Lo, Petra Meier	88
12	Reactivated and latent varicella-zoster virus in human dorsal root ganglia. 1995 ·Proceedings of the National Academy of Sciences ·Octavian Lungu, Paula W. Annunziato, A. A. Gershon, Susan M. Staugaitis, (unknown), Phillip LaRussa, Saul J. Silverstein	120
13	DETERMINATION OF IMMUNITY TO VARICELLA-ZOSTER VIRUS BY MEANS OF AN INTRADERMAL SKIN TEST 1986 ·The Pediatric Infectious Disease Journal ·Phillip LaRussa	1
14	959 EFFICACY OF BOVINE LEUKOCYTE DIALYSATES CONTAINING TRANSFER FACTOR (TF) IN THE THERAPY OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) 1985 ·Pediatric Research ·William Borkowsky, Phillip H. Klesius, Shelley Gordon, Phillip LaRussa, H. Sherwood Lawrence	1
15	A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission. 1985 ·PubMed ·(unknown), Sharon Steinberg, (unknown), Gennaro Galasso, W Borkowsky, Phillip LaRussa, Angelo Ferrara	17
16	Live attenuated varicella vaccine in children with leukemia in remission. 1984 ·PubMed ·Anne A. Gershon, Sharon Steinberg, Gennaro Galasso, W Borkowsky, Phillip LaRussa, Angelo Ferrara, Lawrence Gelb	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact